New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.
Start Your Search

Biden Prepares for Psychedelic Therapy Approval

A new letter from the Health and Human Services Department suggests FDA approval of MDMA and psilocybin treatments is on the horizon.


A recent article from The Intercept_ discussed the Biden administration’s exploration of psychedelic treatments for PTSD and depression. A federal letter revealed that Biden anticipates approval for MDMA and psilocybin as designated breakthrough therapies. The correspondence dates back to May, but was just recently shared with the public. Apparently the administration is exploring the idea of creating a federal task force to monitor psychedelic treatment developments. The full letter can be seen here.

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Take Quiz
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Unlock Learning Here
Discover Our Content Hub